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The complementary role of hyperglycemia and p27kip1 suppression on islet beta cell regeneration was investigated in a syngeneic
mouse model. p27kip1 gene silencing was performed by infecting islets of C57BL/6 with shRNA lentiviral particles. At 54 hours
after viral infection, p27kip1 protein content in cultured targeting islets was 22% of that in freshly isolated islets. Six days after
transplantation to diabetic mice, targeting islet graft had considerably more cells with Ki67-staining nuclei than nontargeting
islets. The mice in the targeting-islet group had a signiﬁcantly shorter duration of temporary hyperglycaemia than mice in the
non-targeting-islet group. The long-term ex vivo beneﬁcial eﬀect of p27kip1 silencing on graft function was also indicated by the
signiﬁcantly higher cumulative cure rate for diabetes in mice receiving 200 targeting islets than that in mice receiving 200 non-
targeting islets. Our data suggest that hyperglycemia and persistent p27kip1 suppression have a synergistic eﬀect on islet beta cell
replication in adult mice.
1.Introduction
Blood glucose homeostasis can be disturbed by many clinical
conditions such as pregnancy and obesity and cause β-cell
mass expansion to meet the increased demand of insulin [1,
2]. However, the mechanism of action underlying the expan-
sion of β-cells is currently unclear [3–6]. Although glucose
has been postulated to regulate cyclin D2 in pancreatic islet
betacellsandplayadominantroleinbetacellcompensation,
it is not yet clear how glucose controls cell cycle of islet beta
cells [7–10]. A previous study showed that the suppression
of both cdk-inhibitors p27kip1 and p18INK4c,b u tn o tp 2 7 Kip1
alone, promotes endocrine tumour formation in rodents
[11, 12]. Similarly, although cyclin D is important for cell
proliferation, its overexpression does not trigger beta cell
replication [13]. It suggests that adult islets are under multi-
points control to regulate cell cycles for beta cell replication.
Our previous study revealed that primary islets of adult
mice respond to chemical-mechanical digestion and puriﬁ-
cation procedures by markedly increasing cyclin B1 but
reducing p27Kip1 protein level [14]. During the following 7
days of cultivation, maintenance of high level of cyclin B1
but rapid restoration of p27Kip1 of islets cultured in medium
containing high glucose was noted [14]. The rapid restora-
tion of p27kip1 level of cultured islets may explain the reason
why cell number did not increase for fetal rat islet beta cells
that are cultured in a medium containing 200mg/dL glucose
for 7 days [15]. Since the p27Kip1 is an important G1/G0
checkpoint forthe progression of cellcycle,it is interesting to
study whether persistent suppression of p27kip1 can enhance
islet beta cell proliferation in a hyperglycaemic milieu. Since
data obtained from experiments using cell lines, fetal islets
or islets of knock-out mice to elucidate the role of p27kip1
and glucose on beta cell replication may not be suitable
for applying to adult islets, in this study, we used primary
islets of adult mice to investigate the complementary role of
hyperglycemiaandpersistentp27kip1 suppressiononbetacell
regeneration.
2.MaterialsandMethods
Chemicals including Tris(hydroxyl-methyl)-aminomethane
(Tris), histopaque-1077, type XI collagenase, and antibody2 International Journal of Endocrinology
against β-actin (AC-15) were obtained from the Sigma
Chemical Company (St. Louis, Mo, USA). RPMI-1640 me-
diumwaspurchasedfromGIBCOInvitrogen,LifeTechnolo-
gies, Inc. (Grand Island, NY, USA). Antibodies against cyclin
B1 (GNS1), cyclin D1 (DCS-6), and p27kip1 (DCS-72.F6)
were obtained from Thermo Fisher Scientiﬁc (Fremont, CA,
USA), and antibody against FoxM1 (4G3) was purchased
from Millipore Corporation (Bilerica, Mass, USA). Rabbit
againstmouseKi67polyclonalantiserum(ab15580)waspur-
chased from Abcam Inc. (Cambridge, MA, USA).
2.1. Animal Care and Induction of Diabetes. Male C57BL/6
mice (8–12 weeks old) were obtained from a local breeder
and were administered a single intraperitoneal injection of
streptozotocin 200mg/kg body weight to induce diabetes.
Mice with whole blood glucose levels remaining at >360mg/
dL for more than 2 weeks were used as diabetic recipients.
Three to 5 mice were housed in each cage and fed standard
pelletedfoodandtapwateradlibitum.Theanimalroomhad
an automatic lighting cycle with 12h of light and 12h of
darkness. The animals were treated humanely in accor-
dance with the laboratory animal guidelines of Chang-Gung
Memorial Hospital.
2.2. Islet Isolation. Pancreatic islets were isolated from
C57BL/6 mice by collagenase digestion, enriched on a histo-
paque density gradient, and ﬁnally hand picked. Brieﬂy, after
administering sodium amobarbital to the mice to induce
anaesthesia, we distended the pancreas of each nonfasted
healthy mouse with 2.5mL RPMI-1640 medium containing
1.5mg/mL collagenase and then excised and incubated these
in a 37◦C water bath. The islets were puriﬁed using a den-
sitygradientandwerehand-pickedunderadissectingmicro-
scope. Isolated islets with diameters of 150μmw e r ec o l l e c t e d
andseparatedintogroupsof50isletspergroup.Tominimize
the inﬂuence of batch-to-batch variation in islet function on
the experimental observations, each batch of islets isolated
from 8–10 mice in a single day were separated into equal
groups and transplanted into an equal number of mice in
both the control and experimental groups on the same day.
2.3. Renal Subcapsular Transplantation. The islets were cen-
trifuged (500g for 90 seconds) in a PE-50 tube connected to
a 200μL pipette tip. With the recipient mouse under amo-
barbital anaesthesia, the left kidney was exposed through a
lumbar incision. A capsulotomy was performed in the lower
pole of the kidney, and the tip of the PE-50 tube (Clay Ad-
ams,Parsippany,NJ,USA)wasadvancedbeneaththecapsule
toward the upper pole, where the islet graft was implanted
using a Hamilton syringe. The capsule was left unsutured.
The retroperitoneal cavity was closed using a 2-layered
suture.
2.4. Targeting and Nontargeting Lentiviral Transduction to
Silence p27kip1 in Islets. We transduced islets with small hair-
pin RNAs (shRNAs) to silence p27kip1 a n du s e dn o n t a r g e t
shRNAs as controls and then examined the eﬀect of p27kip1
silencing on the adaptation of adult mice islets. Brieﬂy,
freshly isolated islets, at a concentration of 50 islets per well,
were plated in a 96-well tissue culture plate with 150μLo f
RPMI-1640 medium containing 8μg/mL of polybrene.
Lentivirus was then incubated with islets at 20 multiplicity
of infection (MOI) for 24h at 37◦C. The next day, the islets
were transferred to new plates, washed twice, and further
cultured at 37◦C, with the medium being changed on a daily
basis. At 72h following isolation, the islets were collected
for transplantation. p27kip1 gene silencing was performed by
infecting the islets with 4 clones of MISSION shRNA Lenti-
viral Particles (Sigma, Saint Louis, MO, USA) that are de-
signed to target cyclin-dependent kinase inhibitor 1B
(p27kip1). These 4 clones were TRCN0000071063, (CCGGC-
GCAAGTGGAATTTCGACTTTCTCGAGAAAGTCGAAA-
TTCCACTTGCGTTTTTG); TRCN0000071064, (CCGGC-
CGGCATTTGGTGGACCAAATCTCGAGATTTGGTCCA-
CCAAATGCCGGTTTTTG); TRCN0000071066, (CCGGC-
CTTTAATTGGGTCTCAGGCACTCGAGTGCCTGAGAC-
CCAATTAAAGGTTTTTG); TRCN0000071067, CCGGCC-
CGGTCAATCATGAAGAACTCTCGAGAGTTCTTCATG-
ATTGACCGGGTTTTTG.
2.5. The Eﬀect of p27kip1 Silencing on Islet Cell Cycle Protein In
Vitro. At24hoursoftransduction,equalbatchesoftargeting
and non-targeting islets (about 300 islets per batch) were
washed 3 times with ice-cold phosphate-buﬀered saline and
lysedwithabuﬀercontaining150mmol/LNaCl,0.2mmol/L
ethylenediamine-tetraacetic acid 20mmol/L Tris-HCl (pH
7.4), and 0.5% sodium dodecyl sulfate supplemented
with complete protease inhibitor cocktail (Roche Diagnos-
tic Deutschland GmbH, Mannheim, Germany). After 20-
minute incubation at 4◦C, the lysate was centrifuged at
13,000×gf o r1 5m i n u t e sa t4 ◦C, and the supernatant was
collected as the total islet protein content. Total islet proteins
separated on a 12% sodium dodecyl sulfate polyacrylamide
gel were electrophoretically transferred onto nitrocellulose
membranes. After Ponceau S staining to check transfer eﬃ-
ciency, the membrane was blocked for 2 hours at room tem-
perature with 10% nonfat dry milk (NFDM) in Tris-buﬀered
saline (pH 7.4) containing 0.1% Tween-20 (TBST). It was
then incubated overnight at 4◦C in NFDM-TBST containing
2μg/mL each of antibodies against β-actin (housekeeping),
p27kip1 (G1/G0 checkpoint), cyclin D1 (G1/S), cyclin B1
(G2/M), and FoxM1, washed 3 times with TBST, and incu-
bated for 1.5h at room temperature with horseradish per-
oxidase-conjugated anti-rabbit immunoglobulin G antibody
(0.1μg/mL NFDM-TBST). After 3 washes with TBST, the
boundantibodiesweredetectedbyusingtheVisGlowchemi-
luminescent kit obtained from Visual Protein Biotechnology
(Taipei, Taiwan) and Kodak BioMax MS ﬁlms. The cell cycle
proteins were expressed as the ratio of band density of each
protein over that of β-actin in the same batch of total islet
proteins.
2.6. The Eﬀect of p27kip1 Silencing on Islet Glucose-Stimulation
Insulin Secretion In Vitro. Function of islets transduced with
shRNAs to silence p27kip1 or the non-target shRNA control
were evaluated by glucose-stimulation insulin secretion.International Journal of Endocrinology 3
Table 1: Eﬀect of p27Kip1 silencing on the expression of cell cycle proteins in adult mouse islets. Cellular lysates of freshly isolated mouse
islets and cultured islets at 54 and 96h after infection with lentivirus to silence p27Kip1 were separated on 12% sodium dodecyl sulfate-
polyacrylamide gel and electrophoretically transferred onto a nitrocellulose membrane, which was then incubated with antibodies against
β-actin, p27Kip1, cyclin B1, cyclin D1, and FoxM1. Cellular lysates of control islets were collected at 24, 54, and 96h after infection with virus
carrying non-target shRNAs for the determination of p27Kip1 protein level. Bound antibodies were detected by using a chemiluminescence
kit. The levels of cell cycle proteins were expressed as the ratio of the band density of each protein over that of β-actin of the same batch of
islet proteins. The protein content of freshly isolated islets was used as the standard for comparison to express the changes in the levels of cell
cycle proteins after virus infection. Data were expressed as mean ± standard error. aP < 0.05, bP < 0.01, cP < 0.005 when the indicated mean
was analyzed using the single t-test.
Hours after viral
infection
p27Kip1/actin
non-targeting control
p27Kip1/actin
targeting B1/actin targeting D1/actin targeting FoxM1/actin
targeting
0 1111 1
24 0.56 ± 0.11a, n = 6
54 0.80 ±0.18, n = 40 .22 ±0.06b, n = 49 .40 ±2.42a, n = 40 .97 ±0.11a, n = 41 .31 ±0.10b, n = 4
96 0.95 ±0.24, n = 40 .19 ±0.03c, n = 43 .26 ±0.85a, n = 40 .93 ±0.12b, n = 41 .88 ±0.46a, n = 4
After 24h of transduction and at 3 and 7 days of culturing,
batches of 30 islets per well were sequentially exposed to dif-
ferent concentrations of glucose. Islets were incubated in
100mg/dL glucose for 60min. After the medium was col-
lected, the same batch of islets was then stimulated with
360mg/dL of glucose for 60min. The net insulin secretion
fromtheglucosestimulationtest(GSIS)wascalculatedasthe
diﬀerence of the insulin content between the medium con-
taining 360mg/dL and medium containing 100mg/dL glu-
cose. The stimulation index (SI) was considered as the ratio
of insulin content of the medium containing 360mg/dL of
glucose over that of the medium containing 100mg/dL of
glucose for the same batch of islets.
2.7. The Short-Term Ex Vivo Eﬀects of p27kip1 Silencing on
Islets Cell Replication and Function. To study the short-term
eﬀect of p27kip1 silencing on islet cell function and replica-
tion, mouse islets transduced with shRNAs to p27kip1or the
non-target shRNA control were transplanted to both nor-
moglycemic healthy mice and mice with streptozotocin-in-
duced diabetes. Whole blood glucose and body weight were
measured every other day. Six days after transplantation, the
islet grafts were removed for immunohistochemical exami-
nations. The relative number of cells in the islet graft under-
going replication was estimated by the relative numbers of
cells with nuclei staining positive for Ki67 for an average of
250 cells per graft (n = 4p e rg r o u p ) .
2.8. The Long-Term Ex Vivo Eﬀects of p27kip1 Silencing on
Islets Cell Function. To study the long-term eﬀects of p27
silencing on the function of islet grafts, mouse islets trans-
duced with shRNAs to p27kip1or the non-target shRNA con-
trol were transplanted to mice with streptozotocin-induced
diabetes 24 hours after transduction and 48 hours after in-
cubation in the culture medium. We transplanted 200 islets
per recipient to study the eﬀect of p27 silencing on islet
function in vivo. After transplantation, the body weight and
whole blood glucose level in blood samples drawn from a
tail vein were measured 2 to 3 times a week for 12 weeks,
and the duration of temporary hyperglycaemia was con-
sidered as the period of time between transplantation and
2 consecutive measurements of whole blood glucose level
below 200mg/dL. At the end of the 12-week observation
period, left nephrectomy was performed on all mice to
remove the islet graft. All nephrectomized mice were kept
alive for 2 weeks to conﬁrm graft function, and then, the
pancreas was removed for measuring the insulin content.
2.9. Measurement of Insulin Content. Insulin content in the
pancreas remnant and the islet graft was determined by
usingtheacid-ethanolmethod.Brieﬂy,thepancreasorgraft-
bearing kidney from nonfasted mice was removed randomly
between 8 and 10AM on the indicated date, homogenized
in an acid-ethanol solution, and stored overnight at 4◦C.
After centrifugation at 2400rpm for 30min, the supernatant
was collected and stored at −20◦C. The pancreas remnant
and islet grafts were then homogenized again in a fresh
aliquot of acid-ethanol solution and the insulin was re-
extracted overnight. After centrifugation, the supernatant
was collected and pooled with the ﬁrst extracted sample.
Finally, the insulin concentration was measured using radio-
immunoassay.
2.10. Statistical Analysis. Data are expressed as means ±
standard error. Statistical diﬀerences between means were
analyzed using a paired or unpaired Student’s t-test, as
appropriate. The cumulative cure rate in groups of the long-
term eﬀect study was assessed using the Kaplan-Meier me-
thod. The log rank test was used to analyze diﬀerences in the
c u r er a t e sb e t w e e ng r o u p so fm i c e .Av a l u eo fP<0.05 was
considered signiﬁcant.
3. Results
Table 1 reveals that the lentivirus carrying p27Kip1-targeting
shRNAeﬀectivelydecreasedtheexpressionofp27Kip1 protein
in adult mouse islets at 54 and 96h after infection and
a representative western blot was shown in Figure 1.T h e
p27Kip1 protein content in cultured islets at 54 hours after
viralinfectionwasonly22%thatinfreshlyisolatedislets,and
the suppression of p27Kip1 protein was maintained even after
96 hours of infection. Table 1 shows that the suppression4 International Journal of Endocrinology
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Figure 1: Eﬀect of p27kip1 silencing on the expression of islet
cell cycle proteins. Total islet cell protein contents of targeting
islets were prepared right after isolation (0hr) and at 54 and 96
hours (hrs) after viral infection; separated on a 12% SDS gel
and electrophoretically transferred onto nitrocellulose membranes.
After checking transfer eﬃciency, the membrane was blocked and
incubated overnight in buﬀer containing 2μg/mL each of rabbit
antibodies against mouse p27kip1,c y c l i nD 1 ,β-actin, cyclin B1, and
FoxM1; incubated with horseradish peroxidase-conjugated goat
anti-rabbit immunoglobulin G antibody. The bound antibodies
weredetectedbyusingchemiluminescentkitandﬁlmdevelopment.
The molecular weight is 27kD for p27, 36kD for cyclin D1, 43kD
for β-actin, 62kD for cyclin B1, and 84kD for FoxM1.
of p27Kip1 expression was accompanied by the increment
in the levels of B1 and FoxM1 proteins, which suggest that
the reduced p27Kip1 expression allows islets cells to enter the
cell cycle. The control islets infected with the non-targeting
lentivirus had a p27Kip1/actin ratio of 0.56 ± 0.11 (n = 6),
0.80 ± 0.18 (n = 4), and 0.95 ± 0.24 (n = 4) at 24, 54, and
96 hours after infection, respectively, in comparison with the
ratios obtained for the freshly isolated islets.
To study the eﬀect of lentivirus transfection on islets
function, the glucose-stimulated insulin secretion (GSIS)
and stimulation index (SI) of islets were measured at 3 and 7
days after targeting and non-targeting viral infection. Table 2
shows that the ratio and net diﬀerence of insulin secretion
between 360mg/dL and 100mg/dL glucose of cultured islets
with targeting did not diﬀer from that of islets with non-
targeting viral infection.
To investigate the short-term eﬀect of p27Kip1 silencing
on islet cell proliferation, batches of 50 each of targeting
and non-targeting transduced islets were implanted in the
subcapsular space of the left kidney of normal healthy mice
and B6 mice with streptozotocin-induced diabetes; 6 days
later, the grafts were removed and immunohistochemistry
was performed. When the mice with streptozotocin-induced
diabetes were used as recipients, the number of nuclei
(a)
(b)
Figure 2: Short-term ex vivo eﬀect of p27Kip1 silencing on islet
cell proliferation in diabetic syngeneic recipients. Batches of 50 of
targeting (a) or non-targeting (b) transduced islets were implanted
in the subcapsular space of the left kidney of B6 mice with
streptozotocin-induced diabetes, and grafts were removed 6 days
later for immunohistochemistry by using the anti-Ki67 antibody.
Thedeep-coloredovalstructuresrepresentpositivelystainednuclei.
The black scale bar indicates a length of 10 micrometers.
staining positive for Ki67 was 0.35 ± 0.12 and 0.12 ± 0.07
(n = 4, P<0.05) for grafts of targeting and non-targeting
islets, respectively. Figure 2 shows the typical results of
immunohistochemistry of islets grafts of the targeting group
(Figure 2(a)) and the non-targeting group (Figure 2(b)). In
normal healthy mice, anti-Ki67 antibody staining was hardly
detectable in the nuclei of islet graft cells from both the
targeting and non-targeting groups (data not shown). For
targeting and non-targeting mice in the diabetic recipient
groups,thewholebloodglucoselevelwas373±16mg/dLand
360±6mg/dL (n = 4, P>0.05) at day 0 and 412±20mg/dL
and 429 ± 46mg/dL (n = 4, P>0.05) at day 6 after
implantation, respectively. The body weight for targeting
and non-targeting mice in the diabetic recipient groups was
23.0 ± 0.8gand23.3 ± 1.3g(n = 4, P>0.05) at day 0 and
24.6 ± 0.3gand24.2 ± 1.0g(n = 4, P>0.05) at day 6 after
transplantation respectively.
To study the long-term eﬀect of p27Kip1 silencing on islet
graft function, batches of 200 isogeneic islets with targeting
ornon-targetingtransductionwereimplantedinthesubcap-
sular space of the left kidney of B6 mice with streptozotocin-
induced diabetes, and the whole blood glucose and bodyInternational Journal of Endocrinology 5
Table 2: The eﬀect of p27kip1 silencing on islet glucose-stimulation insulin secretion in vitro. After 24h of transduction and at 3 and 7 days
of culturing, batches of 30 islets per well were sequentially exposed to diﬀerent concentrations of glucose. Islets were incubated in 100mg/dL
glucose for 60min. After the medium was collected, the same batch of islets was washed and then stimulated with 360mg/dL of glucose for
60min. The net diﬀerence of insulin secretion from the glucose stimulation test (GSIS; ng/islet × 60min) was calculated as the diﬀerence of
the insulin content between the medium containing 360mg/dL and medium containing 100mg/dL glucose. The stimulation index (SI) was
considered as the ratio of insulin content of the medium containing 360mg/dL of glucose over that of the medium containing 100mg/dL of
glucose for the same batch of islets.
Time Targeting islet Non-targeting islet control P value
GSIS (ng/islet × 60min) Day 3 0.17 ± 0.02 (n = 6) 0.20 ± 0.02 (n = 10) >0.05
Day 7 0.24 ± 0.09 (n = 6) 0.17 ± 0.02 (n = 12) >0.05
SI Day 3 2.6 ± 0.3( n = 6) 2.8 ± 0.4( n = 10) >0.05
Day 7 2.4 ± 0.3( n = 6) 2.6 ± 0.3( n = 12) >0.05
Table 3: Eﬀect of p27Kip1 silencing on the period of temporary hyperglycaemia and insulin contents of islet graft and pancreatic remnant.
Batches of 200 isogeneic islets with targeting and non-targeting (control) transduction were implanted in the subcapsular space of the left
kidney of B6 mice with streptozotocin-induced diabetes. After transplantation, blood glucose was measured, and the duration of temporary
hyperglycemiawastheperiodbetweentransplantationandthestablerestorationofnormoglycemia(<200mg/dL).Thegraft-bearingkidneys
were removed 12 weeks after transplantation for the measurement of insulin contents. The pancreatic remnants were removed 2 weeks after
nephrectomy for measuring the insulin content. aP<0.05 when the indicated means were analyzed using unpaired Student’s t-test.
No. of Islets Lentivirus N Period of temporary
hyperglycaemia (days) GIC (μg) PIC (μg)
200 Targeting 13 16.5 ±2.9a 1.75 ± 0.18 0.22 ±0.07
200 Control 14 25.9 ±3.5a 1.54 ± 0.17 0.22 ±0.05
weight were measured. As shown in Figures 3(a) and 4,a l l
treated diabetic mice that received 200 islets converted to
normoglycemia, and the mice in the targeting group had
signiﬁcantly shorter temporary hyperglycaemia period than
mice in the non-targeting group (16.5 ± 2.9, n = 13 versus
25.9 ± 3.5, n = 14, P<0.05 in Table 3). The long-term
ex vivo beneﬁcial eﬀect of p27Kip1 silencing on graft function
wasalsoindicatedbythesigniﬁcantlyhighercumulativecure
rate for diabetes in mice receiving 200 targeting islets than
that in mice receiving 200 non-targeting islets (P<0.05)
(Figure 4). At the end of the 12-week observation period,
the grafts were removed to conﬁrm the hypoglycaemic eﬀect.
Three days after the removal of the graft-bearing kidney, the
mice showed rapid elevation of whole blood glucose level
and a signiﬁcant decrease in body weight (Figures 3(a) and
3(b)). There was no diﬀerence between the targeting and
non-targeting groups in terms of insulin contents of the graft
and pancreatic remnant at 12 weeks after transplantation
(Table 3).
4. Discussion
Inthisstudy,wetransducedadultisletswithlentivirus-carry-
ing shRNA to silence 80% of p27Kip1 protein, and the re-
sultant suppression of p27Kip1 expression lasted for over 96
hours after infection. The transduction and the subsequent
p27Kip1 suppression did not inﬂuence islet functions in terms
of glucose-stimulated insulin secretion. It has been demon-
stratedthatsuboptimalnumberofislettissuewasinsuﬃcient
to achieve normoglycemia in diabetic recipient; graft beta
cell replication was increased initially but not by 18 days and
after despite persistent hyperglycemia, and beta cell mass fell
progressively[16].Therefore,inthisstudy,50islettissuesper
recipient are used for short-term transplantation experiment
to render islet beta cell a higher replication rate in diabetic
recipient; 200 islet tissue is used for long-term experiment
in order to shorten the temporary hyperglycemia days and
avoid falling beta cell mass by persistent hyperglycemia. In
the short-term ex vivo study, when normoglycemic healthy
mice were used as recipients, neither control islets nor
islets with p27Kip1 silencing had detectable cells with nuclei
staining positive for Ki67, at 6 days after transplantation.
On the contrary, adult islets with p27Kip1 silencing expressed
more nuclei and higher density of positive Ki67 staining than
thecontrolislets,at6daysaftertheisletsweretransplantedto
mice with streptozotocin-induced diabetes. Our data suggest
that p27Kip1 suppression alone does not enhance islet cell
proliferation in normoglycemic mice but hyperglycemia and
persistent p27Kip1 suppression have a synergistic eﬀect on
islet cell replication in terms of nuclei staining positive
for Ki67. To further conﬁrm the complementary eﬀect of
hyperglycemia and p27Kip1 silencing on beta cell replication,
we transplanted adult mouse islets with or without p27Kip1
silencing to diabetic mice and followed up all treated mice
for 3 months. The beneﬁcial eﬀect of p27Kip1 silencing on
graft replication was indicated by the signiﬁcantly shorter
temporary hyperglycemic period and the signiﬁcantly higher
cumulative cure rate for diabetes in mice receiving targeting
islets than that of mice receiving the same number of non-
targeting islets.
During the early G1 phase of the cell cycle, cyclin D-
cyclin dependent kinase 4/6 catalyzes phosphorylation of
retinoblastoma protein (pRB) and the phosphorylated pRB6 International Journal of Endocrinology
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Figure 3: Long-term ex vivo eﬀect of p27Kip1 silencing on the blood glucose level (a) and body weight (b) in a syngeneic mouse
transplantation model. Each mouse with streptozotocin-induced diabetes was transplanted with 200 mouse islets transduced with either
shRNAs to p27kip1or the non-target shRNA control under the left renal capsule at day 0. After transplantation, blood glucose level and body
weight were measured. At 84 days following transplantation, the graft-bearing kidneys of all mice were removed by nephrectomy (solid
arrow), and all mice were kept alive for 2 weeks before being sacriﬁced. In Figures 3(a) and 2(b), ∗P<0.05, †P<0.01 indicates the marked
mean compared to that on day 84 in the same group using paired Student’s t-test.
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Figure 4: Curves of cumulative diabetes mellitus cure rate for syngeneic islet transplantation. Each streptozotocin-induced diabetic mouse
was transplanted with 200 mouse islets transduced with either shRNAs to p27kip1 or the non-target shRNA control implanted underneath
the left renal capsule at day 0. Cure of diabetes was deﬁned as the stable restoration of normoglycemia (<200mg/dL glucose). Percent cure
50 (%) stands for half number of the transplanted diabetic mice becoming normoglycemia. The beneﬁcial eﬀect of p27kip1 silencing on the
function of islet grafts was reﬂected by the high cumulative cure rate of diabetes. The diﬀerence between two groups was analyzed with the
log rank test. The value of the comparison for targeting versus non-targeting was P<0.05.
inhibits anaphase-promoting complex- (APC/C-) mediated
polyubiquitination and subsequent proteolysis of skp2,
which results in increase of skp2 and decrease of p27Kip1
protein [17]. The degradation of p27Kip1 is essential for cells
to enter G1/S phases for replication and the resultant adap-
tive expansion of pancreatic beta cells [11, 12]. During S-G2-
M phases of each beta cell division, glucose downregulates
cyclin D2 expression that will reduce phosphorylated pRB
and cause decrease of skp2 and increase of p27Kip1 protein
[10, 17]. The increment of p27Kip1 protein during S-G2-
M phases of each beta cell division prevents cells from im-
maturely entering the next cycle [17]. In late G2 phase, the
amount of B1 protein in Xenopus oocytes is 20- to 30-
fold higher than in G1 and a threshold level of cyclin B1International Journal of Endocrinology 7
protein must be reached before mitosis can proceed [18].
Once initiated, progression through mitosis is dependent on
the degradation of several cell cycle regulatory proteins by
APC/C, including cyclin B1 and skp2, which again prevents
cells inappropriately entering other phases during mitosis
[19, 20]. Our previous study revealed that isolated islets
of adult mice persistently express high level of cyclin B1
especially when the culture medium contains high glucose
[14]. In this study, we used shRNAs to silence p27Kip1 and
used hyperglycemia as a complementary factor to examine
thesynergisticeﬀectofglucoseandp27Kip1 ontheadaptation
of adult mice islets. Although the mechanism of action of the
synergistic eﬀect of hyperglycemia and p27Kip1 silencing on
adult islet beta cell replication is not yet clear, we hypothesize
that the persistent suppression of p27Kip1 by lentivirus-car-
rying shRNA on adult islet cells will drive more cells into
the G1/S phase and the high glucose-mediated persistent
elevation of cyclin B1 will prepare more cells to be ready to
enter mitosis and increase beta cell replication.
In conclusion, our data suggested that adult mouse islet
beta cells can replicate when the metabolic demands increase
and there is a synergistic eﬀect of hyperglycemia and concur-
rent suppression of p27Kip1 on islet beta cell replication.
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